SERIO, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 370
AS - Asia 55
NA - Nord America 27
SA - Sud America 5
AF - Africa 1
Totale 458
Nazione #
IT - Italia 355
US - Stati Uniti d'America 26
SG - Singapore 22
VN - Vietnam 14
CN - Cina 13
FR - Francia 4
DE - Germania 3
BR - Brasile 2
GB - Regno Unito 2
HK - Hong Kong 2
AR - Argentina 1
BE - Belgio 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
FI - Finlandia 1
IQ - Iraq 1
JP - Giappone 1
KZ - Kazakistan 1
MX - Messico 1
NL - Olanda 1
RU - Federazione Russa 1
SI - Slovenia 1
TR - Turchia 1
Totale 458
Città #
Genoa 235
Vado Ligure 50
Rapallo 39
Genova 27
San Jose 13
Singapore 12
Ho Chi Minh City 8
Beijing 5
Lauterbourg 4
Frankfurt am Main 3
Ashburn 2
Council Bluffs 2
Hanoi 2
Hong Kong 2
Rome 2
Aktobe 1
Algiers 1
Amsterdam 1
Bordighera 1
Brussels 1
Cardiff 1
Colina 1
Dallas 1
Del Viso 1
Haiphong 1
Helsinki 1
Istanbul 1
Izhevsk 1
Ljubljana 1
Los Angeles 1
Machala 1
Mexico City 1
Minneapolis 1
New Albany 1
Ninh Bình 1
Phoenix 1
Phúc Yên 1
Poplar 1
Pouso Alegre 1
Salvador 1
Tokyo 1
Zurich 1
Totale 433
Nome #
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 170
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 129
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma 96
Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire 76
Totale 471
Categoria #
all - tutte 2.007
article - articoli 2.007
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202233 0 0 0 0 14 0 6 3 5 2 1 2
2022/202351 5 4 1 2 8 4 0 1 8 5 8 5
2023/202476 2 2 1 5 5 13 20 12 0 5 3 8
2024/2025146 5 11 8 8 13 14 17 27 9 10 14 10
2025/2026165 27 12 12 16 25 11 26 6 12 18 0 0
Totale 471